期刊文献+

基于低分子量PEI的不同疏水链修饰的梳状低聚物基因载体

Comblike Oligomers Modified with Different Hydrophobic Chain Based on Low Molecular Weight PEI Were Used as Gene Vectors
下载PDF
导出
摘要 为了探究基于低分子量聚乙烯亚胺(polyethylenimine,PEI)基因载体的转染效率,通过Michael加成反应将PEI 600 Da接枝于含有疏水链的生物可降解聚酯上形成系列梳状聚合物,并将之应用于基因载体;利用核磁氢谱和凝胶渗透色谱对聚合物的化学结构与分子量进行了测定,此外,还利用凝胶电泳实验和绿色荧光蛋白实验研究了聚合物与DNA的结合能力及其复合物的转染性能。结果表明:本文方法成功合成了系列低聚物,并对DNA表现出较好的包裹能力;油酸修饰后的低聚物与DNA复合物在质量比为6.4时转染效果与PEI 25 kDa相当。可见,油酸修饰后的脂质体低聚物有作为非病毒基因载体的前景。 In order to study the transfection effect of gene vector based on low molecular weight polyethylenimine(PEI),Michael addition reaction was used to graft PEI 600 Da onto biodegradable polyesters containing hydrophobic chains to form a series of comblike polymers,and then they were applied to the gene vector.The chemical structure and molecular weight of the polymers were determined by utilizing 1 HNMR and gel permeation chromatography respectively.Additionally,the binding ability of the polymers and DNA,the transfection performance of their complexes were also studied by use of gel electrophoresis and green fluorescent protein assay.The results show that a series of oligomers are successfully synthesized,by which DNA can be packaged well.The transfection effect of oleic acid-modified oligomer/DNA complex is similar to that of PEI 25 kDa at mass ratio 6.4.It is concluded that oleic acid-modified liposome oligomer has the potential to be used as non-viral gene vector.
作者 荀苗苗 袁长春 傅凯 张海燕 马文兵 王志强 李志春 XUN Miao-miao;YUAN Chang-chun;FU Kai;ZHANG Hai-yan;MA Wen-bing;WANG Zhi-qiang;LI Zhi-chun(School of Chemistry and Chemical Engineering,North University of China,Taiyuan 030051,China;Dezhou Industrial Technology Research Institute of North University of China,Dezhou 253034,China)
出处 《科学技术与工程》 北大核心 2023年第19期8107-8113,共7页 Science Technology and Engineering
基金 山西省基础研究计划(20210302123016,201901D211268)。
关键词 基因载体 生物可降解 疏水性 低分子量PEI gene vector biodegradable hydrophobic low molecular weight PEI
  • 相关文献

参考文献6

二级参考文献30

  • 1Koh P K , Faivre-Finn C, Blackhall F H, ei al. Targeted agents innon-small cell lung cancer (NSCLC) : clinical developments and rationalefor the combination with thoracic radiotherapy. Cancer TreatR ev,2012;3 8 (6 ) :626-640.
  • 2Niu C , Liang C Y , Guo J T, ei al. Downregulation and growth inhibitoryrole of FHL1 in lung cancer. Int J Cancer,2012;1 3 0 (1 1 ) :2549- 2556.
  • 3Bussink J, van-der-Kogel A J, Kaanders J H. Activation of the PDK/AKT pathway and implications for radioresistance mechanisms inhead and neck cancer. Lancet Oncol ,2008 ;9 (3 ) :288-296.
  • 4Hillman G G. , Singh-Gupta V , Runyan L , et al. Soy isoflavones radiosensitizelung cancer while mitigating normal tissue injury. RadiotherOncol,2011 ;101(2) :329-336.
  • 5Nishimura Y , Nakagawa K, Takeda K , et al. Phase I/II trial of sequentialchemoradiotherapy using a novel hypoxic cell radiosensitizer,doranidazole ( PR-350) , in patients with locally advanced non-smallcelllung Cancer ( WJTOG -0002). Int J Radiat Oncol Biol Phys,2007;6 9 (3 ) :786-792.
  • 6Cerqueira N M , Fernandes P A , Ramos M J. Understanding ribonucleotidereductase inactivation by gemcitabine. Chemistry, 2007 ; 13(30) :8507- 8015.
  • 7Edelman M J , Schneider C P, Tsai C M, ei al. Randomized phase IIstudy of ixabepilone or paclitaxel plus carboplatin in patients withnon-small-cell lung cancer prospectively stratified by beta-3 tubulinstatus. J Clin Oncol ,2013 ;31 (16) :1990- 1996.
  • 8Camidge D R , Pao W , Sequist L V. Acquired resistance to TKIs insolid tumours: learning from lung cancer. Nat Rev Clin Oncol,2014;11(8) :473-481.
  • 9Marcos S , Gonzalez-Lazaro M, Beccari L , Meisl coordinates a networkof genes implicated in eye development and microphthalmia. Development,2015 ; 142 (17) : 3009-3020.
  • 10Ferreira H J, Heyn H, Vizoso M ,ei al. DNMT3A mutations mediatethe epigenetic reactivation of the leukemogenic factor Meisl in acutemyeloid leukemia. Oncogene ,2015 ; [Epub ahead of print].

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部